用抗体-药物结合物向胆道癌症:分子标和理性组合的进展
Yulin Chen1, Chidan Wan1, Chen Shi2,3
1Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Cancers
|February 27, 2026
概括
抗体与药物合物 (ADCs) 显示出对治疗胆道癌症 (BTCs) 的前景,通过将向抗体输送与强效化疗相结合. 研究正在进行中,以提高这种具有挑战性的疾病的生存率.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 胆道癌 (BTC) 呈现出分子异质性和免疫抑制的微环境,限制了传统治疗的疗效.
- 目前用于BTC的治疗方法对改善患者存活率的需求尚未得到满足.
- 抗体-药物合物 (ADC) 通过将单克隆抗体与细胞毒性有效载荷联系起来,提供了有针对性的方法.
研究的目的:
- 审查目前关于ADC在BTC临床和临床前试验中的应用的证据.
- 总结BTC治疗中ADC的设计原则和临床数据.
- 探索基于ADC的BTC的组合治疗方案.
主要方法:
- 对BTC的ADC进行临床和临床前研究的综合文献综述.
- 对ADCs的功能原理的分析.
- 在BTC中对ADC疗法的试验设计和临床结果的摘要.
主要成果:
- ADCs在治疗BTC方面表现出令人鼓舞的初步结果.
- 各种ADC设计正在评估它们在BTC中的有效性.
- 目前正在收集和分析基于ADC的组合疗法的临床数据.
结论:
- ADCs代表了BTC有前途的有针对性的治疗策略.
- 进一步的研究和临床评估对于优化BTC患者的ADC治疗至关重要.
- 涉及ADC的组合疗法可能会提高BTC的治疗结果.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
8.1K
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.6K
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59